Technical Analysis for RXST - RxSight, Inc.

Grade Last Price % Change Price Change
A 54.92 4.93% 2.58
RXST closed up 4.93 percent on Tuesday, April 23, 2024, on 84 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: May 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish 4.93%
50 DMA Resistance Bearish 4.93%
Bollinger Band Squeeze Range Contraction 4.93%
BB Squeeze Started Range Contraction 4.93%
20 DMA Resistance Bearish 6.48%
50 DMA Resistance Bearish 6.48%
Cup with Handle Other 6.48%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 7 hours ago
20 DMA Support about 10 hours ago
60 Minute Opening Range Breakout about 10 hours ago
Rose Above 10 DMA about 10 hours ago
Up 3% about 10 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Eye Medical Technology Ophthalmology Vision Cataracts Eye Surgery Cataract Surgery Optometry

Is RXST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.21
52 Week Low 17.09
Average Volume 406,275
200-Day Moving Average 37.55
50-Day Moving Average 52.55
20-Day Moving Average 52.81
10-Day Moving Average 53.41
Average True Range 2.55
RSI (14) 57.26
ADX 18.78
+DI 23.96
-DI 14.27
Chandelier Exit (Long, 3 ATRs) 49.56
Chandelier Exit (Short, 3 ATRs) 55.77
Upper Bollinger Bands 56.77
Lower Bollinger Band 48.85
Percent B (%b) 0.77
BandWidth 14.99
MACD Line 0.59
MACD Signal Line 0.66
MACD Histogram -0.0666
Fundamentals Value
Market Cap 1.97 Billion
Num Shares 35.9 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -32.12
Price-to-Sales 23.31
Price-to-Book 10.87
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 58.69
Resistance 3 (R3) 58.39 56.83 58.06
Resistance 2 (R2) 56.83 55.87 56.98 57.85
Resistance 1 (R1) 55.88 55.28 56.36 56.18 57.64
Pivot Point 54.32 54.32 54.56 54.47 54.32
Support 1 (S1) 53.37 53.36 53.85 53.67 52.20
Support 2 (S2) 51.81 52.77 51.96 51.99
Support 3 (S3) 50.86 51.81 51.78
Support 4 (S4) 51.16